Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort study

The novel coronavirus SARS-CoV-2 causes the infectious disease COVID-19. Newly developed mRNA vaccines can prevent the spread of the virus. Headache is the most common neurological symptom in over 50% of those vaccinated. Detailed information about the clinical characteristics of this form of headac...

Descripción completa

Detalles Bibliográficos
Autores principales: Göbel, Carl H, Heinze, Axel, Karstedt, Sarah, Morscheck, Mascha, Tashiro, Lilian, Cirkel, Anna, Hamid, Qutayba, Halwani, Rabih, Temsah, Mohamad-Hani, Ziemann, Malte, Görg, Siegfried, Münte, Thomas, Göbel, Hartmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344581/
https://www.ncbi.nlm.nih.gov/pubmed/34405142
http://dx.doi.org/10.1093/braincomms/fcab169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344581/
https://www.ncbi.nlm.nih.gov/pubmed/34405142
http://dx.doi.org/10.1093/braincomms/fcab169

Ejemplares similares